These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6169181)

  • 41. Regional variation of cytosol androgen receptors throughout the diseased human prostate gland.
    Bowman SP; Barnes DM; Blacklock NJ; Sullivan PJ
    Prostate; 1986; 8(2):167-80. PubMed ID: 2419881
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Binding of methyltrienolone (R1881) to a progesterone receptor-like component of human prostatic cytosol.
    Cowan RA; Cowan SK; Grant JK
    J Endocrinol; 1977 Aug; 74(2):281-9. PubMed ID: 561151
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man.
    Siiteri PK; Wilson JD
    J Clin Invest; 1970 Sep; 49(9):1737-45. PubMed ID: 4194768
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced affinity of the androgen receptor for 5 alpha-dihydrotestosterone but not methyltrienolone in a form of partial androgen resistance. Studies on cultured genital skin fibroblasts.
    Pinsky L; Kaufman M; Chudley AE
    J Clin Invest; 1985 Apr; 75(4):1291-6. PubMed ID: 3872888
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Androgen binding in cytosols and nuclei of human benign hyperplastic prostatic tissue.
    Sirett DA; Grant JK
    J Endocrinol; 1978 Apr; 77(1):101-10. PubMed ID: 76668
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tissue content of dihydrotestosterone in human prostatic hyperplasis is not supranormal.
    Walsh PC; Hutchins GM; Ewing LL
    J Clin Invest; 1983 Nov; 72(5):1772-7. PubMed ID: 6195192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Progestin-binding protein in human benign prostatic hypertrophy.
    Kodama T; Ito M; Sato R; Ito H; Shimazaki J
    Endocrinol Jpn; 1981 Apr; 28(2):175-85. PubMed ID: 6171422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Testosterone-mediated increase in 5 alpha-dihydrotestosterone content, nuclear androgen receptor levels, and cell division in an androgen-independent prostate carcinoma of Noble rats.
    Ho SM; Leav I; Damassa D; Kwan PW; Merk FB; Seto HS
    Cancer Res; 1988 Feb; 48(3):609-14. PubMed ID: 3257169
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence for a specific dihydrotestosterone-binding cytosol receptor in the human prostate.
    Geller J; Cantor T; Albert J
    J Clin Endocrinol Metab; 1975 Nov; 41(5):854-62. PubMed ID: 52654
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The endocrine background of human renal cell carcinoma. V. Binding of the highly potent androgen methyltrienolone (R 1881) by tumour cytosol.
    Bojar H; Maar K; Staib W
    Urol Int; 1980; 35(2):154-60. PubMed ID: 6966435
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Androgen binding and metabolism in the human prostate.
    Attramadal A; Tveter KJ; Weddington SC; Djöseland O; Naess O; Hansson V; Torgersen O
    Vitam Horm; 1975; 33():247-64. PubMed ID: 59460
    [No Abstract]   [Full Text] [Related]  

  • 52. C19O2-Steroid transformations in the human normal, hyperplastic and cancerous prostate.
    Morfin RF; Charles JF; Floch HH
    J Steroid Biochem; 1979 Jul; 11(1B):599-607. PubMed ID: 90752
    [No Abstract]   [Full Text] [Related]  

  • 53. [Comparison of the binding nature of mibolerone to androgen receptor of human prostate with that of R1881].
    Miki H; Oshimo K; Inoue H; Sumi T; Yamashita K; Morimoto T; Monden Y
    Nihon Naibunpi Gakkai Zasshi; 1988 Aug; 64(8):655-65. PubMed ID: 3265669
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Binding of chlormadinone acetate to cytosol from human benign prostatic hypertrophy.
    Kodama T; Wakisaka M; Shimazaki J
    Endocrinol Jpn; 1980 Feb; 27(1):53-7. PubMed ID: 6156069
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Androgen receptor assays in advanced prostatic cancer.
    Buttyan R; Olsson CA
    Urol Clin North Am; 1984 May; 11(2):311-7. PubMed ID: 6375068
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Formation of 5alpha-androstane-3alpha,17beta-diol by normal and hypertrophic human prostate.
    Jacobi GH; Wilson JD
    J Clin Endocrinol Metab; 1977 Jan; 44(1):107-15. PubMed ID: 64471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specific binding of [3H]-methyltrienolone to both progestin and androgen binding components in human benign prostatic hypertrophy (BPH).
    Asselin J; Mélançon R; Gourdeau Y; Labrie F; Bonne C; Raynaud JP
    J Steroid Biochem; 1979 May; 10(5):483-6. PubMed ID: 88546
    [No Abstract]   [Full Text] [Related]  

  • 58. Dihydrotestosterone in prostatic hypertrophy. II. The formation and content of dihydrotestosterone in the hypertrophic canine prostate and the effect of dihydrotestosterone on prostate growth in the dog.
    Gloyna RE; Siiteri PK; Wilson JD
    J Clin Invest; 1970 Sep; 49(9):1746-53. PubMed ID: 4194769
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Progestin binding in benign hyperplastic prostatic tissue.
    Sirett DA
    J Steroid Biochem; 1983 Jul; 19(1A):163-7. PubMed ID: 6193339
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Androgen glucuronide. II. DIfferences in its formation by human normal and benign hyperplastic prostates.
    Chung LW; Coffey DS
    Invest Urol; 1978 Mar; 15(5):385-8. PubMed ID: 76619
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.